WEED : Canopy Growth Corporation Stock Profile
Last Updated: 3/12/2024 0:47:16
Canopy Growth Corporation trades with the ticker WEED on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Looking to invest in Canopy Growth Corporation? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Canopy Growth Corporation trades with the ticker WEED on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.
Overview
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company’s products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Looking to invest in Canopy Growth Corporation? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
WEED.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $370.836MM
PE Ratio:
Price: 4.07 (Updated: 3/12/2024 0:47:16)
Canopy Growth Corporation (WEED) vs Competitors in Drug Manufacturers – Specialty & Generic
Lets see how WEED.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:Aurora Cannabis Inc, Avicanna Inc, Bausch Health Companies Inc, Cardiol Therapeutics Inc, Cronos Group Inc
.Drug Manufacturers – Specialty & Generic Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aurora Cannabis Inc (ACB) | $222.521 | N/A | -0.115 | N/A% |
| Avicanna Inc (AVCN) | $43.759 | N/A | -4.217 | N/A% |
| Bausch Health Companies Inc (BHC) | $4,553.034 | N/A | 15.169 | N/A% |
| Cardiol Therapeutics Inc (CRDL) | $132.181 | N/A | -3.0 | N/A% |
| Cronos Group Inc (CRON) | $1,018.068 | N/A | 1.918 | N/A% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Drug Manufacturers – Specialty & Generic
- Canopy Growth Corporation (WEED) vs Aurora Cannabis Inc (ACB)
- WEED has higher EPS (-21.3 vs -79.2). ACB and WEED both have P/E’s under 0.
- Canopy Growth Corporation (WEED) vs Avicanna Inc (AVCN)
- AVCN has higher EPS (-0.17 vs -21.3). AVCN and WEED both have P/E’s under 0.
- Canopy Growth Corporation (WEED) vs Bausch Health Companies Inc (BHC)
- BHC has higher EPS (-2.18 vs -21.3). BHC and WEED both have P/E’s under 0.
- Canopy Growth Corporation (WEED) vs Cardiol Therapeutics Inc (CRDL)
- CRDL has higher EPS (-0.43 vs -21.3). CRDL and WEED both have P/E’s under 0.
- Canopy Growth Corporation (WEED) vs Cronos Group Inc (CRON)
- CRON has higher EPS (-0.24 vs -21.3). CRON and WEED both have P/E’s under 0.
Our Recommendation: Hold
Shows positive EPS growth from this year to next, suggesting improving profitability. Features a lower EV/EBITDA ratio (-0.86) than the industry average (0.33), indicating attractive valuation.
How to Buy WEED stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |